-
Signature
-
/s/ Anita Beth Adams, as attorney-in-fact
-
Issuer symbol
-
PRVA
-
Transactions as of
-
12 Dec 2025
-
Net transactions value
-
-$550,118
-
Form type
-
4
-
Filing time
-
16 Dec 2025, 16:37:23 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Mountcastle David |
EVP & Chief Financial Officer |
PRIVIA HEALTH GROUP, INC., 950 N. GLEBE RD., SUITE 700, ARLINGTON |
/s/ Anita Beth Adams, as attorney-in-fact |
16 Dec 2025 |
0001858396 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
PRVA |
Common Stock, par value $0.01 per share |
Options Exercise |
$47,774 |
+23,887 |
+14% |
$2.00 |
196,796 |
12 Dec 2025 |
Direct |
F1 |
| transaction |
PRVA |
Common Stock, par value $0.01 per share |
Sale |
$597,892 |
-23,887 |
-12% |
$25.03 |
172,909 |
12 Dec 2025 |
Direct |
F1, F2 |
| holding |
PRVA |
Common Stock, $0.01 par value per share |
|
|
|
|
|
8,695 |
12 Dec 2025 |
By spouse |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
PRVA |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-7,698 |
-30% |
$0.000000 |
17,820 |
12 Dec 2025 |
Common Stock, par value $0.01 per share |
7,698 |
$2.00 |
Direct |
F1, F3 |
| transaction |
PRVA |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-4,792 |
-28% |
$0.000000 |
12,452 |
12 Dec 2025 |
Common Stock, par value $0.01 per share |
4,792 |
$2.00 |
Direct |
F1, F3 |
| transaction |
PRVA |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-3,430 |
-38% |
$0.000000 |
5,501 |
12 Dec 2025 |
Common Stock, par value $0.01 per share |
3,430 |
$2.00 |
Direct |
F1, F3 |
| transaction |
PRVA |
Stock Option (Right to Purchase) |
Options Exercise |
$0 |
-7,967 |
-74% |
$0.000000 |
2,866 |
12 Dec 2025 |
Common Stock, par value $0.01 per share |
7,967 |
$2.00 |
Direct |
F1, F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: